Business Description
Theralink Technologies Inc
NAICS : 621511
SIC : 8071
ISIN : US68235A1016
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Equity-to-Asset | -32.02 | |||||
Debt-to-Equity | -0.42 | |||||
Debt-to-EBITDA | 3.76 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -115.54 | |||||
Beneish M-Score | -61.4 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 61.8 | |||||
3-Year EPS without NRI Growth Rate | 47.4 | |||||
3-Year FCF Growth Rate | 72.3 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
12-1 Month Momentum % | -91.67 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Days Sales Outstanding | 20 | |||||
Days Payable | 2207.71 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.3 | |||||
Shareholder Yield % | -2089.4 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 73.39 | |||||
Operating Margin % | -1214.49 | |||||
Net Margin % | -2125.67 | |||||
FCF Margin % | -781.42 | |||||
ROA % | -569.34 | |||||
ROIC % | -16.15 | |||||
ROC (Joel Greenblatt) % | 372.94 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | 3.98 | |||||
EV-to-EBITDA | 3.85 | |||||
EV-to-Revenue | 38.34 | |||||
EV-to-FCF | -4.91 | |||||
Earnings Yield (Greenblatt) % | 25.13 | |||||
FCF Yield % | -806.83 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:THER
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Theralink Technologies Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 0.635 | ||
EPS (TTM) ($) | -0.004 | ||
Beta | 1.46 | ||
Volatility % | 91.42 | ||
14-Day RSI | 0 | ||
14-Day ATR ($) | 0.000007 | ||
20-Day SMA ($) | 0.0001 | ||
12-1 Month Momentum % | -91.67 | ||
52-Week Range ($) | 0.0001 - 0.0019 | ||
Shares Outstanding (Mil) | 6,151.5 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Theralink Technologies Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Theralink Technologies Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Theralink Technologies Inc Frequently Asked Questions
What is Theralink Technologies Inc(THER)'s stock price today?
When is next earnings date of Theralink Technologies Inc(THER)?
Does Theralink Technologies Inc(THER) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |